ProviderTrust Named to the 2018 Inc. 5000 List

Our ProviderTrust team is so excited to be honored for the third consecutive year on the 2018 Inc. 5000 list as one of the fastest-growing private companies in America. Only 1 in 4 companies have continued to make the list three times, showcasing our continued growth, focus, and service to our customers. We are always challenging ourselves to be engaged in the healthcare community, and are driven by providing simple solutions for compliance and HR professionals. 

Investment Area of Interest: End-of-Life and Palliative Care

End-of-life care is an important part of the care continuum for patients and the families of patients with terminal conditions or those encroaching upon old age. Palliative care is one option for end-of-life care and is specifically focused on symptom and pain management for patients with serious illnesses; it is not necessarily limited to patients in their last days or months of life and can be administered across a variety of care settings (from home to hospital)

Vericred Announces Provider Network Analytics Suite for Insurance Carriers

“Vericred’s new provider network analytics suite offers a graphical, 360 degree view of a carrier’s own networks and those of their competitors,” said Michael W. Levin, Vericred’s co-founder and CEO. “Networks, broad and narrow, are a key health insurance product differentiator. Our network analytics suite, developed based on feedback from carrier partners, helps carriers identify competitive advantages and weaknesses and to curate their networks to strengthen their product offerings.”

FCA VI Closes with $55M and Adds to the Investment Team

FCA Venture Partners is pleased to announce the completion of fundraising for its sixth fund, FCA Venture Partners VI, on April 27th. The Fund closed with $55M of committed capital and has already made investments in five portfolio companies. Consistent with its predecessor fund, FCA VI will focus on early to growth stage companies in the healthcare IT and technology sectors with disruptive, scalable business models.

Clinical Ink To Accelerate Innovation And Growth With Major Investment By NovaQuest Private Equity

Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, today announced that the private equity team at NovaQuest Capital Management, L.L.C. ("NovaQuest") has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital. The deep clinical, operational, and financial resources of NovaQuest will allow Clinical Ink to aggressively pursue growth opportunities and fuel investment in new products and operational capabilities.